Complications métaboliques et rénales chroniques du traitement par sels de lithium
Authors:
- 1 September 2019
- journal article
- review article
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 40 (9) , 599-608
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysisBMJ, 2013
- Vasopressin: a novel target for the prevention and retardation of kidney disease?Nature Reviews Nephrology, 2013
- PTH-independent regulation of blood calcium concentration by the calcium-sensing receptorJournal of Clinical Investigation, 2012
- Tissue injury after lithium treatment in human and rat postnatal kidney involves glycogen synthase kinase-3β-positive epitheliumAmerican Journal of Physiology-Renal Physiology, 2012
- Lithium toxicity profile: a systematic review and meta-analysisThe Lancet, 2012
- Low-dose lithium uptake promotes longevity in humans and metazoansEuropean Journal of Nutrition, 2011
- GSK3β Mediates Renal Response to Vasopressin by Modulating Adenylate Cyclase ActivityJournal of the American Society of Nephrology, 2010
- Lithium-induced Nephrogenic Diabetes InsipidusClinical Journal of the American Society of Nephrology, 2008
- pVHL and GSK3β are components of a primary cilium-maintenance signalling networkNature Cell Biology, 2007
- Effects of long-term lithium infusion on normal parathyroid tissueSurgery, 1995